Emerging Vaccine Injury Accountability and Recovery Act (EVIRA)
“Supporting Americans with Transparency, Access, and Respect.”
Purpose:
To provide federal recognition, resources, and support to Americans who believe they have experienced serious adverse health effects following COVID-19 vaccination—including aggressive cancers, autoimmune disorders, neurological conditions, and reproductive issues—and to advance transparency, investigation, and care without stigma.
TITLE I: Expanded Support for Potential Vaccine-Injured Individuals
Section 101 — Medical Assistance Grant Program
Creates a new federal grant fund through HHS that offers financial support for medical diagnostics and care to individuals who develop serious illness (e.g., cancers, autoimmune disorders, heart conditions) within 12 months post-vaccination and are not already compensated through the National Vaccine Injury Compensation Program (VICP).Section 102 — Mental Health & Grief Services
Funds counseling and grief support for families of individuals who died from complications that may be connected to a COVID-19 vaccination. Delivered via partnerships with community health centers and telehealth providers.Section 103 — Emergency Financial Relief Bridge
Offers temporary financial relief (up to $25,000) to affected individuals or their families while their cases are investigated, especially if they are unable to work due to illness or side effects.
TITLE II: National Investigation and Research Expansion
Section 201 — National Adverse Event Research Initiative
Establishes a specialized NIH-funded research consortium to investigate long-term effects of mRNA and adenovirus-based vaccines, including rare cancers, immune dysregulation, and neurological impacts.Section 202 — Clinical Registry of Emerging Cases
Mandates the creation of a national database that allows individuals to voluntarily report post-vaccine adverse conditions, symptoms, and diagnoses. Data will be anonymized and reviewed by independent experts.Section 203 — VAERS Reform and Oversight
Requires an overhaul of the Vaccine Adverse Event Reporting System (VAERS) to ensure timely data analysis, public accessibility, and follow-up on serious cases reported. Includes an independent oversight board composed of medical professionals, patient advocates, and statisticians.
TITLE III: Legal & Transparency Protections
Section 301 — Statutory Recognition of COVID-19 Vaccine Injury
Requires HHS and CDC to publicly recognize that post-vaccination health impacts—including rare but serious conditions—exist, even if causality is still under investigation.Section 302 — No Retaliation Clause
Prohibits discrimination or professional retaliation against healthcare workers, researchers, or patients who report or treat suspected vaccine injuries.Section 303 — Review of CICP (Countermeasures Injury Compensation Program)
Requires a GAO audit of the CICP’s effectiveness and fairness, with recommendations to increase transparency, timeliness, and public trust.
TITLE IV: Public Information & Accountability
Section 401 — Federal Information Portal
Creates a federal website where individuals can report symptoms, track legislation and data related to vaccine injury, and access resources including legal aid and clinical care networks.Section 402 — Congressional Report
Mandates an annual report to Congress on emerging adverse events and government response effectiveness, reviewed by an independent, bipartisan advisory panel.
Why It Matters:
Victims of potential vaccine injury deserve dignity, access to care, and transparency, not censorship or silence.
This Act upholds medical freedom without dismantling public health infrastructure or pushing anti-vaccine sentiment.
It provides a thoughtful, science-backed path forward for understanding emerging issues—while preparing government systems to better respond in the future.
